Dual Activation‐Induced Marker Combinations Efficiently Identify and Discern Antigen‐Specific and Bystander‐Activated Human CD4 <sup>+</sup> T Cells
Identifying activated T lymphocytes and differentiating antigen-specific from bystander T cells is crucial for understanding adaptive immune responses. This study investigates the efficacy of activation-induced markers (AIMs) in distinguishing these cell populations. We measured the expression of commonly used AIMs (CD25, CD38, CD40L, CD69, CD137, HLA-DR, ICOS, and OX40) in an in vitro T-cell activation system and evaluated their sensitivity, specificity, and positive predictive value. We demonstrated that individual AIMs, while specific in detecting activated CD4<sup>+</sup> T cells, poorly discriminate between antigen-specific and bystander activation, as assessed by a discriminative capacity (DC) score we developed. Our analysis revealed that dual AIM combinations significantly enhanced the ability to distinguish antigen-specific from bystander-activated T cells, achieving DC scores above 90%. These combinations also improved positive predictive value and specificity with a modest reduction in sensitivity. The CD25<sup>hi</sup>/ICOS<sup>hi</sup> combination emerged as the most efficient, with an average sensitivity of 84.35%, specificity of 99.7%, and DC score of 90.12%. Validation through T-cell cloning and antigen re-stimulation confirmed the robustness of our predictions. This study provides a practical framework for researchers to optimize strategies for identifying and isolating antigen-specific human CD4<sup>+</sup> T lymphocytes and studying their phenotype, function, and T-cell receptor repertoire.
Authors
- Sergio Abrignani (ORCID: https://orcid.org/0000-0002-0794-3285)
- Federica Sallusto (ORCID: https://orcid.org/0000-0003-3750-2752)
- Mauro Bombaci (ORCID: https://orcid.org/0000-0002-9887-4165)
- Daniele Prati (ORCID: https://orcid.org/0000-0002-2281-7498)
- Antonio Lanzavecchia (ORCID: https://orcid.org/0000-0002-3041-7240)
- Alessandra Bandera (ORCID: https://orcid.org/0000-0001-9440-4601)
- Riccardo Ungaro
- Samuele Notarbartolo (ORCID: https://orcid.org/0000-0001-5910-4910)
- Antonino Cassotta (ORCID: https://orcid.org/0000-0001-8674-4294)
- S Triolo
- Maristella Leccese
- Maria Grazia Ceraolo
- Elena Coluccio
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- ETH Zurich (CH)
- Centre for Multidisciplinary Research in Health Science (IT)
- Istituto Nazionale Genetica Molecolare (IT)
- Università della Svizzera italiana (CH)
Publication Details
- Journal
- European Journal of Immunology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1002/eji.202451404
- Citations
- 4
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.96
Funders
- Ministero della Salute